New Deal
Graham Robinson
Partner at Skadden Arps Slate Meagher & Flom
Lawyer
Boston
Deal Bio
Awards
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (58)
Key Relationships
Announcement Date
Deal Value
Juno Therapeutics
Celgene Corporation
£5,862m
60 dealmakers
Kite Pharma
Gilead Sciences
£9,302m
24 dealmakers
Wework Companies
Softbank Group Corp
value n/a
16 dealmakers
Webroot
Carbonite
£477m
19 dealmakers
Clementia Pharmaceuticals
IPSEN
£995m
41 dealmakers
Nightstar Therapeutics
Biogen
£663m
30 dealmakers
Array Biopharma
Pfizer
£9,049m
51 dealmakers
Galapagos
£849m
36 dealmakers
Semma Therapeutics
Vertex Pharmaceuticals
£785m
26 dealmakers
Alder Biopharmaceuticals
Lundbeck As
£1,559m
10 dealmakers
Bioverativ
Sanofi
£7,852m
45 dealmakers
Achillion Pharmaceuticals
Alexion Pharmaceuticals
£732m
21 dealmakers
OPENTEXT
£1,110m
47 dealmakers
Arqule
Merck Kgaa
£2,054m
62 dealmakers
£3,472m
33 dealmakers
Legg Mason
Franklin Templeton Investments Corporation
£4,990m
63 dealmakers
Forty Seven
£3,821m
48 dealmakers
Stemline Therapeutics
Menarini Group
£541m
44 dealmakers
Portola Pharmaceuticals
£1,306m
50 dealmakers
Momenta Pharmaceuticals
Johnson & Johnson
£4,929m
57 dealmakers
Cersci Therapeutics
Acadia Pharmaceuticals
£717m
20 dealmakers
Akcea Therapeutics
Ionis Pharmaceuticals
£334m
Wework China
Trustbridge Partners
£157m
14 dealmakers
Urovant Sciences
Sumitovant Biopharma
£144m
13 dealmakers
Boston Dynamics
Hyundai Motor Group
£695m
34 dealmakers
National Holdings
B. Riley Financial
Gw Pharmaceuticals
Jazz Pharmaceuticals
£5,266m
85 dealmakers
Pandion Therapeutics
Merck & Co
£1,308m
28 dealmakers
Five Prime Therapeutics
Amgen
£1,361m
Bow Capital
£6,532m
107 dealmakers
STRONGBRIDGE
Xeris Pharmaceuticals
£188m
53 dealmakers
Constellation Pharmaceuticals
Morphosys
£1,198m
58 dealmakers
Translate Bio
£2,302m
52 dealmakers
Amicus Therapeutics (gene Therapy Business)
Arya Sciences Acquisition Corp Iv
£440m
25 dealmakers
Acceleron Pharma
£8,528m
80 dealmakers
Aspen Technology
Emerson Electric Co
£8,081m
49 dealmakers
DICERNA
Novo Nordisk
£2,452m
23 dealmakers
BOTTOMLINE
Thoma Bravo
£1,956m
Sierra Oncology
Glaxosmithkline
£1,522m
Antares Pharma
HALOZYME
£737m
59 dealmakers
Biohaven Pharmaceutical Holding Company
£9,417m
VIACYTE
£265m
42 dealmakers
Aerie Pharmaceuticals
Alcon
£650m
Cincor Pharma
Astrazeneca
£1,487m
79 dealmakers
Seagen
£35,705m
66 dealmakers
Prometheus Biosciences
£8,698m
Bellus Health
£1,614m
17 dealmakers
Iveric Bio
Astellas Pharma
£4,693m
22 dealmakers
Cti Biopharma
Swedish Orphan Biovitrum (sobi)
£1,347m
76 dealmakers
Intercept Pharmaceuticals
Alfasigma
£649m
31 dealmakers
Point Biopharma
Eli Lilly And Company
£1,152m
40 dealmakers
Mirati Therapeutics
Bristol Myers Squibb Company
£3,840m
54 dealmakers
ENGAGESMART
Vista Equity Partners
£3,288m
Cerevel Therapeutics
Abbvie
£6,894m
Ambrx
£1,493m
38 dealmakers
Novartis
£2,309m
93 dealmakers
Cymabay Therapeutics
£3,404m
Alpine Immune Sciences
£3,867m